News Related to Voxelotor

Related coverage linked through entity extraction aliases.

Gene Therapy for Sickle Cell Disease Remains Unaffordable in Africa Despite US, UK Approvals

Feb 26, 2026

Approved gene-editing therapies for sickle cell disease priced at $2.2 million remain out of reach in Africa, where 80% of the world's cases occur, as Uganda launches mandatory newborn screening.

Drug Hunter Highlights Notable Small Molecules from July Through December 2025

Aug 15, 2025

Drug Hunter's monthly molecule selections from July through December 2025 feature innovative small molecule candidates targeting pain, epilepsy, cancer, infectious diseases, and metabolic disorders, including non-opioid pain agents and precision therapies for rare conditions.